FIELD: medicine.
SUBSTANCE: present invention refers to medicine and concerns microparticles containing sphere mainly consisting of cross-linked agarose carbohydrate and allergen covalently bonded with sphere, applied for immune system disturbance treatment. Used allergen is produced of plant pollen, specifically of timothy grass pollen. Application of specified microparticles provides effective treatment for patients suffering from allergy, as well as reduces by-effects of parenteral introduction.
EFFECT: development of effective method of allergy treatment and prevention.
9 cl, 4 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
| HYPOALLERGENIC VARIANTS OF MAL D 1, MAIN MALUS DOMECTICA ALLERGEN | 2012 |
|
RU2624030C2 |
| VARIANTS OF GROUP 5 ALLERGENS OF CEREALS WITH REDUCED ALLERGENICITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2658767C1 |
| VERSIONS OF GROUP OF 5 ALLERGENS OF TRUE GRASSES WITH REDUCED ALLERGENICITY RESULTING FROM MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2575606C2 |
| NEW WHEAT ALLERGENS | 2008 |
|
RU2502742C2 |
| COMPOSITION, STIMULATING IMMUNE RESPONSE, WHICH CONTAINS NANOPARTICLES BASED ON COPOLYMER OF METHYLVINYL ETHER OF MALEIC ANHYDRIDE | 2005 |
|
RU2379028C2 |
| RECOMBINANT POLYPEPTIDE BASED ON BIRCH POLLEN ALLERGEN AND APPLE ALLERGEN AS AN ALLERGY VACCINE | 2020 |
|
RU2761431C1 |
| VACCINE SHOWING CAPABILITY TO CAUSE IMMUNE RESPONSE AGAINST THE SELF-IGE BODY, METHOD OF VACCINE PREPARING AND METHOD OF MAMMAL IMMUNIZATION AGAINST IGE-MEDIATED ALLERGIC RESPONSES | 1992 |
|
RU2120805C1 |
| MODIFICATION OF GROUP 6 POACEAE (BLUEGRASS) ALLERGENS WITH LOW ALLERGENIC CAPACITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2607373C2 |
| METHOD FOR ENCAPSULATING ALLERGENS INTO CHITOSAN PARTICLES TO REDUCE RECOGNITION OF ALLERGENS BY IgE ANTIBODIES DURING ALLERGEN-SPECIFIC SUBCUTANEOUS AND TRANSEPIDERMAL IMMUNOTHERAPY | 2020 |
|
RU2760672C1 |
